Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans - PubMed (original) (raw)
Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans
P Marteau et al. Am J Clin Nutr. 1990 Oct.
Abstract
Nine healthy volunteers were studied before, during, and after ingesting a fermented dairy product containing Lactobacillus acidophilus, Bifidobacterium bifidum, and mesophilic cultures (Streptococcus lactis and S cremoris) for 3 wk. Hydrogen and methane productions and fecal beta-galactosidase and beta-glucosidase activities were measured as indicators of fermentation capacity of the colonic flora. Fecal concentrations of nitroreductase, azoreductase, and beta-glucuronidase, which may be implicated in colonic carcinogenesis, were also assessed. Hydrogen and methane productions, fecal beta-galactosidase, beta-glucuronidase, and azoreductase activities did not change over three 3-wk periods whereas fecal beta-glucosidase activity increased (42 +/- 6, 91 +/- 12, and 40 +/- 6 IU/g N, P less than 0.01) and nitroreductase decreased (0.87 +/- 0.13, 0.54 +/- 0.11, and 0.57 +/- 0.08 IU/g N, P less than 0.05).
Similar articles
- Cell-free whey from milk fermented with Bifidobacterium breve C50 used to modify the colonic microflora of healthy subjects.
Romond MB, Ais A, Guillemot F, Bounouader R, Cortot A, Romond C. Romond MB, et al. J Dairy Sci. 1998 May;81(5):1229-35. doi: 10.3168/jds.S0022-0302(98)75683-8. J Dairy Sci. 1998. PMID: 9621224 - Effects of Lactobacillus acidophilus on gut microflora metabolic biomarkers in fed and fasted rats.
Mountzouris KC, Kotzampassi K, Tsirtsikos P, Kapoutzis K, Fegeros K. Mountzouris KC, et al. Clin Nutr. 2009 Jun;28(3):318-24. doi: 10.1016/j.clnu.2009.01.009. Epub 2009 Feb 14. Clin Nutr. 2009. PMID: 19223094 - Effects of fructo-oligosaccharides ingestion on fecal bifidobacteria and selected metabolic indexes of colon carcinogenesis in healthy humans.
Bouhnik Y, Flourié B, Riottot M, Bisetti N, Gailing MF, Guibert A, Bornet F, Rambaud JC. Bouhnik Y, et al. Nutr Cancer. 1996;26(1):21-9. doi: 10.1080/01635589609514459. Nutr Cancer. 1996. PMID: 8844718 Clinical Trial. - The role of oxygen in the viability of probiotic bacteria with reference to L. acidophilus and Bifidobacterium spp.
Talwalkar A, Kailasapathy K. Talwalkar A, et al. Curr Issues Intest Microbiol. 2004 Mar;5(1):1-8. Curr Issues Intest Microbiol. 2004. PMID: 15055922 Review. - Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection.
Salminen S, Salminen E. Salminen S, et al. Scand J Gastroenterol Suppl. 1997;222:45-8. doi: 10.1080/00365521.1997.11720717. Scand J Gastroenterol Suppl. 1997. PMID: 9145446 Review.
Cited by
- Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: a randomized controlled trial [ISRCTN10820810].
St-Onge MP, Farnworth ER, Savard T, Chabot D, Mafu A, Jones PJ. St-Onge MP, et al. BMC Complement Altern Med. 2002;2:1. doi: 10.1186/1472-6882-2-1. Epub 2002 Jan 22. BMC Complement Altern Med. 2002. PMID: 11825344 Free PMC article. Clinical Trial. - Particulate Cell Wall Materials of Lactobacillus acidophilus as Vaccine Adjuvant.
Lin SC, Chang PC, Lin CH, Liang HJ, Huang CH. Lin SC, et al. Vet Sci. 2022 Dec 15;9(12):698. doi: 10.3390/vetsci9120698. Vet Sci. 2022. PMID: 36548859 Free PMC article. - Potential Mechanisms of Probiotics Action in the Prevention and Treatment of Colorectal Cancer.
Molska M, Reguła J. Molska M, et al. Nutrients. 2019 Oct 14;11(10):2453. doi: 10.3390/nu11102453. Nutrients. 2019. PMID: 31615096 Free PMC article. Review. - Dietary supplementation of different doses of NUTRIOSE FB, a fermentable dextrin, alters the activity of faecal enzymes in healthy men.
van den Heuvel EG, Wils D, Pasman WJ, Saniez MH, Kardinaal AF. van den Heuvel EG, et al. Eur J Nutr. 2005 Oct;44(7):445-51. doi: 10.1007/s00394-005-0552-0. Epub 2005 Feb 9. Eur J Nutr. 2005. PMID: 15696402 Clinical Trial. - Prognostic impact of fecal pH in critically ill patients.
Osuka A, Shimizu K, Ogura H, Tasaki O, Hamasaki T, Asahara T, Nomoto K, Morotomi M, Kuwagata Y, Shimazu T. Osuka A, et al. Crit Care. 2012 Jul 10;16(4):R119. doi: 10.1186/cc11413. Crit Care. 2012. PMID: 22776285 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources